3-amino-N-(2,3-dimethyl-phenyl)benzenesulphonamide | 244013-66-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-amino-N-(2,3-dimethyl-phenyl)benzenesulphonamide
• 英文别名: 3-amino-N-(2,3-dimethylphenylbenzene sulphonamide)；3-amino-N-(2,3-dimethylphenyl)benzenesulfonamide
• CAS: 244013-66-9
• 化学式: C₁₄H₁₆N₂O₂S
• 分子量: 276.359
• InChiKey: SPYRPJAQBBRKRT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-amino-N-(2,3-dimethyl-phenyl)benzenesulphonamide 在 N-甲基吗啉 、 盐酸 、 氯甲酸异丁酯 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 2(S)-2-(hexadecanoylamino)-3-[[3-(2,3-dimethylphenylaminosulphonyl)phenyl]-aminocarbonyl]propionic acid benzyl ester
  参考文献：
  名称：

  Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity

  摘要：

  DOI：

  10.1211/146080800128735601
• 作为产物：
  描述：

  2,3-二甲基苯胺 在 N-甲基吗啉 、 tin(ll) chloride 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 16.0h， 生成 3-amino-N-(2,3-dimethyl-phenyl)benzenesulphonamide
  参考文献：
  名称：

  法呢基转移酶新型模块化双底物类似物抑制剂的设计、合成和评价。

  摘要：

  可以从法呢基转移酶抑制剂开发用于治疗癌症的有前景的潜在化学疗法。提出了一类新的模块化双底物法呢基转移酶抑制剂，可以直接合成。这种抑制剂的一个例子是化合物 1，其 IC50 值为 3.7 μM。

  DOI：

  10.1002/(sici)1521-3773(19990712)38:13/14<2032::aid-anie2032>3.0.co;2-d

文献信息

• Design, Synthesis, and Evaluation of Novel Modular Bisubstrate Analogue Inhibitors of Farnesyltransferase
  作者：Martin Schlitzer、Isabel Sattler

  DOI：10.1002/(sici)1521-3773(19990712)38:13/14<2032::aid-anie2032>3.0.co;2-d

  日期：1999.7.12

  Promising potential chemotherapeutics for the treatment of cancer can be developed from farnesyltransferase inhibitors. A novel class of modular bisubstrate farnesyltransferase inhibitors is presented that can be synthesized in a straightforward manner. An example of such an inhibitor is compound 1, which has an IC50 value of 3.7 μM.

  可以从法呢基转移酶抑制剂开发用于治疗癌症的有前景的潜在化学疗法。提出了一类新的模块化双底物法呢基转移酶抑制剂，可以直接合成。这种抑制剂的一个例子是化合物 1，其 IC50 值为 3.7 μM。
• Different Amino Acid Replacements in CAAX-Tetrapeptide Based Peptidomimetic Farnesyltransferase Inhibitors
  作者：Martin Schlitzer、Isabel Sattler、Hans-Martin Dahse

  DOI：10.1002/(sici)1521-4184(19994)332:4<124::aid-ardp124>3.0.co;2-g

  日期：1999.4

  In a series of CAAX-tetrapeptide based farnesyltransferase inhibitors it has been shown that the central AA-dipeptide can be replaced by tranexamic acid, 4-aminobenzenesulfonic acid, and 3-amino-N-(2,3-dimethylphenyl)benzenesulfonamide, respectively, yielding inhibitors active in the low micromolar range. Lipophilic derivatives of these compounds showed moderate anti-proliferative activity against different tumor cell lines. A promising class of peptidomimetic farnesyltransferase inhibitors was discovered through the replacement of the terminal AAX motif of the CAAX-tetrapeptide by 2-acylamino-5-aminobenzophenones.
• Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group
  作者：M. Schlitzer、I. Sattler

  DOI：10.1211/146080800128735746

  日期：2000.3.1
• Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity
  作者：M. Schlitzer、I. Sattler

  DOI：10.1211/146080800128735601

  日期：2000.11.1
• Design, synthesis and early structure–activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate
  作者：Martin Schlitzer、Markus Böhm、Isabel Sattler、Hans-Martin Dahse

  DOI：10.1016/s0968-0896(00)00138-3

  日期：2000.8

  Inhibition of the farnesylation of ras proteins has been identified as a promising target in tumor therapy. Only a few farnesyltransferase inhibitors are bisubstrate analogues displaying features of both substrates, the farnesylpyrophosphate and the C-terminal CAAX-tetrapeptide sequence of the res protein. These known bisubstrate analogues consist of an AAX-tripeptide and a farnesyl residue connected through various linkers. We have developed a class of novel compounds that mimic a bisubstrate inhibitor structure and that differ from the known ones by lacking peptidic or farnesylic substructures. Long chain fatty acids and aryl-substituted carboxylic acids were used as farnesyl surrogates. These structures were linked to isoleucine amide, benzoic acid amide, N-substituted aminobenzenesulfonamides and N-alpha-aryl-substituted methionine derivatives, respectively, which function as AA- or AAX-mimetics. (C) 2000 Elsevier Science Ltd. All rights reserved.